套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011741 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011745 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-20-131132 Act: 33 Size: 126 KB 网页链接
$Lyra Therapeutics(LYRA)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001193125-20-131089 Act: 33 Size: 3 MB 网页链接
$Lyra Therapeutics(LYRA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000931 Act: 33 Size: 1 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011655 Size: 8 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011657 Size: 8 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011658 Size: 8 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011659 Size: 12 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-011663 Size: 11 KB 网页链接